These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15147457)

  • 1. Orthopedic and neurological complications of cervical dystonia--review of the literature.
    Konrad C; Vollmer-Haase J; Anneken K; Knecht S
    Acta Neurol Scand; 2004 Jun; 109(6):369-73. PubMed ID: 15147457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peri-operative treatment with botulinum A toxin prior to posterior cervical decompression in a case with cervical spondylosis caused by spasmodic torticollis secondary to cerebral palsy].
    Iwamuro H; Takahashi H; Ide K; Nakauchi J; Taniguchi M
    No Shinkei Geka; 2003 Sep; 31(9):1015-20. PubMed ID: 14513786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary cervical dystonia associated with structural lesions of the central nervous system.
    LeDoux MS; Brady KA
    Mov Disord; 2003 Jan; 18(1):60-9. PubMed ID: 12518301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurosurgical management of dystonias].
    Taira T
    Rinsho Shinkeigaku; 2006 Nov; 46(11):970-1. PubMed ID: 17432236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia.
    Cano SJ; Hobart JC; Edwards M; Fitzpatrick R; Bhatia K; Thompson AJ; Warner TT
    Neurology; 2006 Dec; 67(12):2230-2. PubMed ID: 17190951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current status and prospects of medical therapy for dystonia].
    Osawa M
    Rinsho Shinkeigaku; 2006 Nov; 46(11):967-9. PubMed ID: 17432235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of primary focal or segmental dystonia in adults in the district of foggia, southern Italy: a service-based study.
    Papantonio AM; Beghi E; Fogli D; Zarrelli M; Logroscino G; Bentivoglio A; Simone P; Tonali P; Specchio LM
    Neuroepidemiology; 2009; 33(2):117-23. PubMed ID: 19556806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical dystonia: disease profile and clinical management.
    Crowner BE
    Phys Ther; 2007 Nov; 87(11):1511-26. PubMed ID: 17878433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.
    Ihde SK; Konstantinovic VS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical dystonia (spasmodic torticollis). Some aspects of the natural history.
    Van Zandijcke M
    Acta Neurol Belg; 1995 Dec; 95(4):210-5. PubMed ID: 8553794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-lived response of cervical dystonia to electroconvulsive therapy.
    Garcia RF; Dias AG; de Freitas AR; Fontenelle LF
    J ECT; 2009 Jun; 25(2):135-6. PubMed ID: 19145211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of focal and generalized dystonia in Rochester, Minnesota.
    Nutt JG; Muenter MD; Aronson A; Kurland LT; Melton LJ
    Mov Disord; 1988; 3(3):188-94. PubMed ID: 3264051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The study and treatment of dystonias in childhood].
    Pascual-Pascual SI
    Rev Neurol; 2006 Oct; 43 Suppl 1():S161-8. PubMed ID: 17061184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiotherapy in cervical dystonia: six experimental single-case studies.
    Zetterberg L; Halvorsen K; Färnstrand C; Aquilonius SM; Lindmark B
    Physiother Theory Pract; 2008; 24(4):275-90. PubMed ID: 18574753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of dystonia in Japan].
    Mezaki T; Hayashi A; Nakase H; Hasegawa K
    Rinsho Shinkeigaku; 2005 Sep; 45(9):634-42. PubMed ID: 16248394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spasmodic torticollis: clinical and biologic features and their implications for focal dystonia.
    Duane DD
    Adv Neurol; 1988; 50():473-92. PubMed ID: 3400504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of botulinum toxin A for headache in cervical dystonia.
    Ondo WG; Gollomp S; Galvez-Jimenez N
    Headache; 2005 Sep; 45(8):1073-7. PubMed ID: 16109123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The entity of young onset primary cervical dystonia.
    Koukouni V; Martino D; Arabia G; Quinn NP; Bhatia KP
    Mov Disord; 2007 Apr; 22(6):843-7. PubMed ID: 17357144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new screening tool for cervical dystonia.
    Saunders-Pullman R; Soto-Valencia J; Costan-Toth C; Shriberg J; Raymond D; Derby CA; Lipton RB; Bressman SB
    Neurology; 2005 Jun; 64(12):2046-9. PubMed ID: 15985569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.